TherapeuticsMD (NASDAQ:TXMD) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of TherapeuticsMD (NASDAQ:TXMD) in a report issued on Wednesday. The firm issued a hold rating on the stock.

TherapeuticsMD Trading Up 0.9 %

TXMD stock opened at $1.15 on Wednesday. The firm has a 50 day moving average price of $0.93 and a 200-day moving average price of $1.15. TherapeuticsMD has a 52-week low of $0.70 and a 52-week high of $2.44.

TherapeuticsMD Company Profile

TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.